Global C5 Complement Inhibitors Drug Market Opportunity USD 15 Billion 2026

Global C5 Complement Inhibitors Drug Market Opportunity USD 15 Billion 2026

News Highlights

DELHI, India, April 17, 2021 (News) — “Global C5 Complement Inhibitors Drug Market Opportunity, Drug Price, Sales & Clinical Trials Insight 2026” Report Highlights:

  • Global C5 Complement Inhibitors Drug Market Opportunity: > USD 15 Billion
  • Global C5 Complement Inhibitors Drug Market Absolute Growth: 65% (2017 -2020)
  • Global C5 Complement Inhibitors Drug Market Growth In 2020: 21% (> USD 5 Billion)
  • Commercially Available C5 Complement Inhibitors Drugs: 3 (Soliris, Ultomiris & Elizaria)
  • Soliris (Eculizumab) Sales In 2020: > USD 3 Billion

Download Report:

https://www.kuickresearch.com/report-global-us-japan-c5-c5a-eculizumab-complement-inhibitor-inhibitors-drugs-drug-market-sales-size-complement-inhibitor-clinical-trials-anti-c5-soliris-eculizumab-elizaria–sales-ultomiris-ravulizumab-paroxysmal-nocturnal-hemoglobinuria

“Global C5 Complement Inhibitors Drug Market Opportunity, Drug Price, Sales & Clinical Trials Insight 2026” provides comprehensive insight on clinical and non-clinical factors that are driving the global C5 Complement Inhibitors market and its impact on the global pharmaceutical market landscape. The report has been prepared in a view to deeply profile the current market trends along with the sales insight on 3 commercially available C5 Complement Inhibitors with their regional level revenue, market share and the clinical profile.

During the past few years, the researchers of leading pharmaceutical companies are focusing on the role of complement system in the development and management of several immune related complications. C5 complement inhibitors are first in class drugs for targeting complement cascade, which are widely accepted among the patients due to high efficacy and safety profile of this category. Due to unavailability of the alternative treatment the demand of C5 complement inhibitors in increasing continuously and this segment is witnessing tremendous growth and emerging as one of the leading drug class in the orphan disease healthcare sector.

Currently two drugs of this therapeutic class i.e. Soliris and Ultomiris are commercially available in the market. After the approval of second drug of this category, an intense growth in the C5 inhibitor market is observed and this market is expected to grow with higher momentum during next few years. Along with this, the biosimilar of Soliris was also available in Russia, which is also triggering the market size of this segment.

As C5 inhibitors have potential to target several rare disorders such as paroxysmal nocturnal hemoglobinuria, hemolytic uremic syndrome, myasthenia gravis and neuromyelitis optica spectrum disorder, the researchers are focusing to identify and develop novel drugs of this category and several new candidates entered the clinical trials during the past few years. The clinical trials are not only faced on the autoimmune disease but they are also exploring the role of C5 components in conditions such as Covid-19, kidney disease, hematological disease and many other complications, In addition to this, the researchers also identified the role of complement system in the development of cancer and hence it is expected that the researchers also initiate investigations for development of cancer targeting C5 complement inhibitors in near future..

  • Check the latest Business news updates and information updates.
  • Please share this news Global C5 Complement Inhibitors Drug Market Opportunity USD 15 Billion 2026 with your friends and family to support us your one share helps us a lot.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
FESPA launches virtual events to Boost Business recovery

FESPA launches virtual events to Boost Business recovery

These interactive online events are each themed around a particular area of technology and application, giving visitors a focused environment to engage with ...
Sharkoon Launches its Light-sqaure 180 Gaming Mouse

Sharkoon Launches its Light-sqaure 180 Gaming Mouse

A particularly pleasant handling is offered by the low weight of the Light² 180 at only 63 grams. Furthermore, the honeycomb structure of the upper shell ...
Most health decision makers prioritize the provision of virtual care, says Philips report

Most health decision makers prioritize the provision of virtual care, says Philips report

“It is this reinvigorated spirit of collaboration that will truly advance the industry, helping to establish a much-needed foundational technology ...
Updated 21/04: CFTC Crypto Charges & Settlements Timeline – Finance and Banking

Updated 21/04: CFTC Crypto Charges & Settlements Timeline – Finance and Banking

POPULAR ARTICLES ON: Finance and Banking from United States The content of this article is intended to provide a general guide to the subject matter. ...
IIFL Finance fourth quarter results: Net income jumps to Rs 248 cr

IIFL Finance fourth quarter results: Net income jumps to Rs 248 cr

IIFL Finance Chairman Nirmal Jain said employees of the company continued to render their services to the customers despite the pandemic that has helped ...
Final Fantasy 7 Remake Intergrade will be a PS5 exclusive until at least December 10th

Final Fantasy 7 Remake Intergrade will be a PS5 exclusive until at least December 10th

Final Fantasy 7 Remake Part 2 will pick up where Intergrade ends.  Intergrade will launch alongside Final Fantasy 7 Remake: Episode Intermission, a ...
Dr. Escott transitions to the role of Medical Director

Dr. Escott transitions to the role of Medical Director

SIGN UP FOR FOX 7 AUSTIN EMAIL ALERTS Escott has served as interim health authority since 2019 when Austin was grappling with the first toxic algae blooms in ...
Save big bucks on Amazon Echo speakers and many more

Save big bucks on Amazon Echo speakers and many more

Moving on to Smart displays, you can currently get a new Echo Show 10 with a $50 discount, which leaves it available for just $200. You can also score a free ...
Best Speakers to Upgrade Your TV Setup

Best Speakers to Upgrade Your TV Setup

Adding just a few good quality external speakers into the mix can alter your audio exponentially, adding dimensions to your sound, and delivering highs and ...
Show next
Compsmag - Latest News from tech, business and health
Logo